TETRAPENTYLAMMONIUM

ID: ALA2074704

Max Phase: Preclinical

Molecular Formula: C20H44N+

Molecular Weight: 298.58

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCC[N+](CCCCC)(CCCCC)CCCCC

Standard InChI:  InChI=1S/C20H44N/c1-5-9-13-17-21(18-14-10-6-2,19-15-11-7-3)20-16-12-8-4/h5-20H2,1-4H3/q+1

Standard InChI Key:  GJSGYPDDPQRWPK-UHFFFAOYSA-N

Associated Targets(Human)

Solute carrier family 22 member 2 261 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Solute carrier family 22 member 1 646 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Solute carrier family 22 member 1 176 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Solute carrier family 22 member 2 136 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Solute carrier family 22 member 1 31 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 298.58Molecular Weight (Monoisotopic): 298.3468AlogP: 6.56#Rotatable Bonds: 16
Polar Surface Area: 0.00Molecular Species: HBA: 0HBD: 0
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 3.10CX LogD: 3.10
Aromatic Rings: 0Heavy Atoms: 21QED Weighted: 0.22Np Likeness Score: 0.17

References

1. Zhang L, Schaner ME, Giacomini KM..  (1998)  Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).,  286  (1): [PMID:9655880]
2. Sweet DH, Miller DS, Pritchard JB..  (2001)  Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus.,  276  (1): [PMID:11553644] [10.1074/jbc.m108472200]
3. Bednarczyk D, Ekins S, Wikel JH, Wright SH..  (2003)  Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.,  63  (1): [PMID:12606755] [10.1124/mol.63.3.489]
4. Dresser MJ, Gray AT, Giacomini KM..  (2000)  Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).,  292  (1): [PMID:10688634]
5. Gorboulev V, Volk C, Arndt P, Akhoundova A, Koepsell H..  (1999)  Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate.,  56  (1): [PMID:10570053] [10.1124/mol.56.6.1254]
6. Urakami Y, Okuda M, Masuda S, Akazawa M, Saito H, Inui K..  (2001)  Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules.,  18  (1): [PMID:11758759] [10.1023/a:1013070128668]
7. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H..  (1994)  Drug excretion mediated by a new prototype of polyspecific transporter.,  372  (1): [PMID:7990927] [10.1038/372549a0]
8. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H..  (1997)  Cloning and characterization of two human polyspecific organic cation transporters.,  16  (1): [PMID:9260930] [10.1089/dna.1997.16.871]